GAME-CHANGING DRUGS FOR MASH: WHAT PATIENTS NEED TO KNOW

Game-Changing Drugs for MASH: What Patients Need to Know Revolutionizing MASH Treatment: The Impact of Rezdiffra's Approval The FDA's approval of Rezdiffra marks a pivotal moment in the treatment of metabolic-associated steatohepatitis (MASH), significantly altering the landscape of care for this liver disease. Unlike previous treatments, whi